Indy Hematology Review

http://www.indyhematologyreview.com/

 

Indy Hematology Review
R

MPNs: Risk Stratification and Therapy - A Global Perspective

By Indy Hematology Review FEATURING Ruben Mesa
By Indy Hematology Review FEATURING Ruben Mesa
10 views
September 6, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
2021
30:17
Indy Hematology Review

Management of Long-Term Survivors of Hematologic Malignancies

Feat. K. Orbaugh
29:05
Indy Hematology Review

Aggressive Lymphoma - Nursing and Allied Providers Symposium

Feat. J. Leonard
31:05
Indy Hematology Review

CLL: A Decade of Remarkable Progress

Feat. S. Coutre
26:57
Indy Hematology Review

How I Treat Symptom Burden in MPNs

Feat. R. Mesa
19:07
Indy Hematology Review

Recognizing Toxicities of Oral Oncolytics in the Management of Hemat…

Feat. D. Reeves
20:04
Indy Hematology Review

Myeloma & Waldenstrom: Overview and Updates on New Therapies

Feat. M. Gertz
36:33
Indy Hematology Review

Multiple Myeloma: The Cure Around the Corner

Feat. K. Anderson
19:58
Indy Hematology Review

Updates in the Waldenstrom’s Macroglobulinemia Management

Feat. S. Treon
30:18
Indy Hematology Review

CML: Changing Goals

Feat. R. Larson
27:56
Indy Hematology Review

Indolent and Mantle Cell Lymphoma: Updating the Toolbox, Including a…

Feat. S. Smith
27:15
Indy Hematology Review

Aggressive B-Cell and T-Cell Lymphomas: Emerging Therapies

Feat. J. Leonard
27:08
Indy Hematology Review

ALL Biologic and Targeted Therapies

Feat. H. Kantarjian
31:21
Indy Hematology Review

Benign Hematology: Clotting, Bleeding, and More

Feat. C. Kessler
38:32
Indy Hematology Review

State of the Art: Current and Emerging Treatment of Hodgkin’s Lympho…

Feat. R. Advani
26:01
Indy Hematology Review

CLL: Curability and Duration of Therapy

Feat. J. Woyach
22:49
Indy Hematology Review

CLL: Management After 1L Therapy

Feat. B. D. Cheson
24:45
Indy Hematology Review

MPNs: Risk Stratification and Therapy - A Global Perspective

Feat. R. Mesa
26:58
Indy Hematology Review

Mastocytosis and Eosinophilia: The Vexing Disorders of the Blood

Feat. A. Tefferi
37:25
Indy Hematology Review

Initial Therapy of AML: Finally, a Trip Beyond 7+3

Feat. H. Erba
27:44
Indy Hematology Review

MDS: Emerging and Targeted Therapies

Feat. R. Stone
25:37
Indy Hematology Review

Hematopoietic Stem Cell Transplantation: Updating the Old Closet

Feat. R. Childs